Cancer Genetics – a Jewish Perspective

Genetic studies are playing an increasingly important role in cancer medicine. This is no longer confined to epidemiology and disease susceptibility, although such studies remain very important. Today, translation of genetic information into the clinic is influencing treatment choices significantly, and contributing to “personalised medicine”.

Recently Dr Ian Ellis, Consultant Clinical Geneticist at Royal Liverpool and Alder Hey Hospitals*, reviewed the Jewish perspective on this topic for Chai Cancer Care. To access this informative article click here.


Jnetics* is the only charity dedicated to improving the management and prevention of Jewish genetic disorders (JGDs) in the UK.

Jnetics works to improve awareness and access to carrier screening for severe, recessive JGDs to reduce the incidence of these devastating conditions.  They also raise awareness of heredity cancers that are relatively more prevalent among Jewish people and how these can be better managed.

In 2017, working in partnership with the NHS, Jnetics launched its GENEius Programme – an education and screening initiative targeted at young Jewish adults. GENEius is fully endorsed by all the synagogue movements and key community leadership organisations. The programme aims to change the mindset of the Jewish community so that JGD education and screening becomes standard practice in the UK, as it has been for many years in other Jewish communities abroad.

GENEius delivers education about JGDs and the importance of screening to Jewish sixth formers, Jewish university students and couples going through the synagogue pre-marriage process. Year 12 and university students are offered screening as an integrated part of the GENEius programme, whereas pre-marriage couples and others in the community can access screening via the Jnetics’ clinic based at Barnet Hospital.

For more information about Jnetics and its activities, please visit:

* Formerly known as Jewish Genetic Disorders UK (JGD UK)


Website created by
Creative & Commercial